Works matching AU Kyle, Robert A.


Results: 295
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemia.

    Published in:
    1975
    By:
    • Carey, Robert W.;
    • Ribas-Mundo, Manuel;
    • Ellison, Rose Ruth;
    • Glidewell, Oliver;
    • Lee, Stanley T.;
    • Cuttner, Janet;
    • Levy, Robert N.;
    • Silver, Richard;
    • Blom, Johannes;
    • Haurani, Farid;
    • Spurr, Charles L.;
    • Harley, John B.;
    • Kyle, Robert;
    • Moon, John H.;
    • Eagan, Richard T.;
    • Holland, James H.;
    • Carey, R W;
    • Ribas-Mundo, M;
    • Ellison, R R;
    • Glidewell, O
    Publication type:
    journal article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Overuse of organ biopsies in immunoglobulin light chain amyloidosis (AL): the consequence of failure of early recognition.

    Published in:
    Annals of Medicine, 2017, v. 49, n. 7, p. 545, doi. 10.1080/07853890.2017.1304649
    By:
    • Muchtar, Eli;
    • Dispenzieri, Angela;
    • Lacy, Martha Q.;
    • Buadi, Francis K.;
    • Kapoor, Prashant;
    • Hayman, Suzanne R.;
    • Gonsalves, Wilson;
    • Warsame, Rahma;
    • Kourelis, Taxiarchis V.;
    • Chakraborty, Rajshekhar;
    • Russell, Stephen;
    • Lust, John A.;
    • Lin, Yi;
    • Go, Ronald S.;
    • Zeldenrust, Steven;
    • Rajkumar, S. Vincent;
    • Dingli, David;
    • Leung, Nelson;
    • Kyle, Robert A.;
    • Kumar, Shaji K.
    Publication type:
    Article
    21
    22
    23
    24
    25

    The treatment of multiple myeloma using vincristine, carmustine, melphalan, cyclophosphamide, and prednisone (VBMCP) alternating with high-dose cyclophosphamide and alpha(2)beta interferon versus VBMCP: results of a phase III Eastern Cooperative Oncology Group Study E5A93.

    Published in:
    2009
    By:
    • Kyle RA;
    • Jacobus S;
    • Friedenberg WR;
    • Slabber CF;
    • Rajkumar SV;
    • Greipp PR;
    • Kyle, Robert A;
    • Jacobus, Susanna;
    • Friedenberg, William R;
    • Slabber, Coenraad Frederik;
    • Rajkumar, S Vincent;
    • Greipp, Philip R
    Publication type:
    journal article
    26

    Expert review on soft‐tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations.

    Published in:
    British Journal of Haematology, 2021, v. 194, n. 3, p. 496, doi. 10.1111/bjh.17338
    By:
    • Rosiñol, Laura;
    • Beksac, Meral;
    • Zamagni, Elena;
    • Van de Donk, Niels W. C. J.;
    • Anderson, Kenneth C.;
    • Badros, Ashraf;
    • Caers, Jo;
    • Cavo, Michele;
    • Dimopoulos, Meletios‐Athanasios;
    • Dispenzieri, Angela;
    • Einsele, Hermann;
    • Engelhardt, Monika;
    • Fernández de Larrea, Carlos;
    • Gahrton, Gösta;
    • Gay, Francesca;
    • Hájek, Roman;
    • Hungria, Vania;
    • Jurczyszyn, Artur;
    • Kröger, Nicolaus;
    • Kyle, Robert A.
    Publication type:
    Article
    27

    Implications of detecting serum monoclonal protein by MASS‐fix following stem cell transplantation in multiple myeloma.

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 2, p. 380, doi. 10.1111/bjh.17195
    By:
    • Abeykoon, Jithma P.;
    • Murray, David L.;
    • Murray, Isaiah;
    • Jevremovic, Dragan;
    • Otteson, Gregory E.;
    • Dispenzieri, Angela;
    • Arendt, Bonnie K.;
    • Dasari, Surendra;
    • Gertz, Morie;
    • Gonsalves, Wilson I.;
    • Kourelis, Taxiarchis V.;
    • Muchtar, Eli;
    • Dingli, David;
    • Warsame, Rahma;
    • Go, Ronald S.;
    • Lacy, Martha Q.;
    • Leung, Nelson;
    • Buadi, Francis;
    • Lin, Yi;
    • Kyle, Robert A.
    Publication type:
    Article
    28
    29
    30
    31
    32

    Association of Thrombocytopenia With Disease Burden, High-Risk Cytogenetics, and Survival in Newly Diagnosed Multiple Myeloma Patients Treated With Novel Therapies.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 10, p. e329, doi. 10.1016/j.clml.2024.05.020
    By:
    • Charalampous, Charalampos;
    • Goel, Utkarsh;
    • Kapoor, Prashant;
    • Binder, Moritz;
    • Buadi, Francis;
    • Dingli, David;
    • Dispenzieri, Angela;
    • Fonder, Amie;
    • Gertz, Morie;
    • Gonsalves, Wilson;
    • Hayman, Suzanne;
    • Hobbs, Miriam;
    • Hwa, Yi Lisa;
    • Kourelis, Taxiarchis;
    • Lacy, Martha;
    • Leung, Nelson;
    • Lin, Yi;
    • Warsame, Rahma;
    • Kyle, Robert A.;
    • Rajkumar, Vincent
    Publication type:
    Article
    33

    Predictors and Impact of Timing of Disease Progression Following Primary Therapy in Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 3, p. e104, doi. 10.1016/j.clml.2023.11.008
    By:
    • Goldman-Mazur, Sarah;
    • Visram, Alissa;
    • Rajkumar, S. Vincent;
    • Kapoor, Prashant;
    • Dispenzieri, Angela;
    • Lacy, Martha Q.;
    • Gertz, Morie A.;
    • Buadi, Francis K.;
    • Hayman, Suzanne R.;
    • Dingli, David;
    • Kourelis, Taxiarchis;
    • Gonsalves, Wilson;
    • Warsame, Rahma;
    • Muchtar, Eli;
    • Leung, Nelson;
    • Kyle, Robert A.;
    • Kumar, Shaji K.
    Publication type:
    Article
    34

    P-140: Monoclonal proteinuria ≥200 mg/24h predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S111, doi. 10.1016/S2152-2650(21)02267-9
    By:
    • Visram, Alissa;
    • Rajkumar, S. Vincent;
    • Kapoor, Prashant;
    • Dispenzieri, Angela;
    • Lacy, Martha;
    • Gertz, Morie;
    • Buadi, Francis;
    • Hayman, Suzanne;
    • Dingli, David;
    • kourelis, Taxiarchis;
    • Gonsalves, Wilson;
    • Warsame, Rahma;
    • Muchtar, Eli;
    • Leung, Nelson;
    • Kyle, Robert;
    • Kumar, Shaji
    Publication type:
    Article
    35

    OAB-037: Assessing the prognostic utility of the Mayo 2018 and IMWG 2020 smoldering multiple myeloma risk stratification scores applied post diagnosis.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S24, doi. 10.1016/S2152-2650(21)02111-X
    By:
    • Visram, Alissa;
    • Rajkumar, S. Vincent;
    • Kapoor, Prashant;
    • Dispenzieri, Angela;
    • Lacy, Martha;
    • Gertz, Morie;
    • Buadi, Francis;
    • Hayman, Suzanne;
    • Dingli, David;
    • kourelis, Taxiarchis;
    • Gonsalves, Wilson;
    • Warsame, Rahma;
    • Muchtar, Eli;
    • Leung, Nelson;
    • Kyle, Robert;
    • Kumar, Shaji
    Publication type:
    Article
    36

    MM-431: A Comparison Between Daratumumab and Non-Daratumumab-Based Salvage Regimens Used at First Relapse Post-Lenalidomide Maintenance in Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S444, doi. 10.1016/S2152-2650(21)01987-X
    By:
    • Ho, Matthew;
    • Zanwar, Saurabh;
    • Kapoor, Prashant;
    • Gertz, Morie;
    • Lacy, Martha;
    • Dispenzieri, Angela;
    • Hayman, Suzanne;
    • Dingli, David;
    • Buadi, Francis;
    • Leung, Nelson;
    • Kourelis, Taxiarchis;
    • Warsame, Rahma;
    • Fonder, Amie;
    • Hwa, Lisa;
    • Hobbs, Miriam;
    • Kyle, Robert;
    • Rajkumar, Vincent;
    • Kumar, Shaji
    Publication type:
    Article
    37

    MM-429: Impact of Prolonged Lenalidomide Maintenance (≥3 years) and Outcomes in Patients with Multiple Myeloma Post-Autologous Stem Cell Transplant.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S443, doi. 10.1016/S2152-2650(21)01986-8
    By:
    • Zanwar, Saurabh;
    • Ho, Matthew;
    • Kapoor, Prashant;
    • Gertz, Morie;
    • Lacy, Martha;
    • Dispenzieri, Angela;
    • Hayman, Suzanne;
    • Dingli, David;
    • Buadi, Francis;
    • Leung, Nelson;
    • Kourelis, Taxiarchis;
    • Warsame, Rahma;
    • Fonder, Amie;
    • Yi Hwa;
    • Hobbs, Miriam;
    • Kyle, Robert;
    • Rajkumar, Vincent;
    • Kumar, Shaji
    Publication type:
    Article
    38

    MM-315: Impact of Stratification of Levels of Serum Lactate Dehydrogenase (LDH) at Diagnosis on Overall Survival (OS) in Newly Diagnosed Multiple Myeloma (NDMM).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S435, doi. 10.1016/S2152-2650(21)01970-4
    By:
    • Evans, Laura A.;
    • Kumar, Shaji K.;
    • Dispenzieri, Angela;
    • Buadi, Francis K.;
    • Dingli, David;
    • Lacy, Martha Q.;
    • Hayman, Suzanne R.;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis V.;
    • Muchtar, Eli;
    • Go, Ronald S.;
    • Warsame, Rahma;
    • Leung, Nelson;
    • Hobbs, Miriam;
    • Hwa, Y. Lisa;
    • Fonder, Amie;
    • Kyle, Robert A.;
    • Gertz, Morie;
    • Rajkumar, S. Vincent;
    • Gonsalves, Wilson I.
    Publication type:
    Article
    39

    Poster: MM-431: A Comparison Between Daratumumab and Non-Daratumumab-Based Salvage Regimens Used at First Relapse Post-Lenalidomide Maintenance in Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S256, doi. 10.1016/S2152-2650(21)01611-6
    By:
    • Ho, Matthew;
    • Zanwar, Saurabh;
    • Kapoor, Prashant;
    • Gertz, Morie;
    • Lacy, Martha;
    • Dispenzieri, Angela;
    • Hayman, Suzanne;
    • Dingli, David;
    • Buadi, Francis;
    • Leung, Nelson;
    • Kourelis, Taxiarchis;
    • Warsame, Rahma;
    • Fonder, Amie;
    • Hwa, Lisa;
    • Hobbs, Miriam;
    • Kyle, Robert;
    • Rajkumar, Vincent;
    • Kumar, Shaji
    Publication type:
    Article
    40

    Poster: MM-315: Impact of Stratification of Levels of Serum Lactate Dehydrogenase (LDH) at Diagnosis on Overall Survival (OS) in Newly Diagnosed Multiple Myeloma (NDMM).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S255, doi. 10.1016/S2152-2650(21)01605-0
    By:
    • Evans, Laura A.;
    • Kumar, Shaji K.;
    • Dispenzieri, Angela;
    • Buadi, Francis K.;
    • Dingli, David;
    • Lacy, Martha Q.;
    • Hayman, Suzanne R.;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis V.;
    • Muchtar, Eli;
    • Go, Ronald S.;
    • Warsame, Rahma;
    • Leung, Nelson;
    • Hobbs, Miriam;
    • Hwa, Y. Lisa;
    • Fonder, Amie;
    • Kyle, Robert A.;
    • Gertz, Morie;
    • Rajkumar, S. Vincent;
    • Gonsalves, Wilson I.
    Publication type:
    Article
    41

    Poster: MM-429: Impact of Prolonged Lenalidomide Maintenance (≥3 years) and Outcomes in Patients with Multiple Myeloma Post-Autologous Stem Cell Transplant.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S252, doi. 10.1016/S2152-2650(21)01580-9
    By:
    • Zanwar, Saurabh;
    • Ho, Matthew;
    • Kapoor, Prashant;
    • Gertz, Morie;
    • Lacy, Martha;
    • Dispenzieri, Angela;
    • Hayman, Suzanne;
    • Dingli, David;
    • Buadi, Francis;
    • Leung, Nelson;
    • Kourelis, Taxiarchis;
    • Warsame, Rahma;
    • Fonder, Amie;
    • Hwa, Yi;
    • Hobbs, Miriam;
    • Kyle, Robert;
    • Rajkumar, Vincent;
    • Kumar, Shaji
    Publication type:
    Article
    42
    43
    44

    The role of bone marrow biopsy in patients with plasma cell disorders; should all patients with a monoclonal protein be biopsied?

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e333, doi. 10.1016/j.clml.2019.09.547
    By:
    • Sidiqi, M Hasib;
    • Aljama, Mohammed;
    • Kumar, Shaji;
    • Jevremovic, Dragan;
    • Buadi, Francis;
    • Warsame, Rahma;
    • Lacy, Martha;
    • Dingli, David;
    • Gonsalves, Wilson;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis;
    • Leung, Nelson;
    • Muchtar, Eli;
    • Lust, John;
    • Kyle, Robert;
    • Go, Ronald;
    • Rajkumar, S.Vincent;
    • Gertz, Morie A.;
    • Dispenzieri, Angela
    Publication type:
    Article
    45

    Impact of Minimal Residual Negativity on Outcomes in Light Chain Amyloidosis.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e331, doi. 10.1016/j.clml.2019.09.545
    By:
    • Sidana, Surbhi;
    • Muchtar, Eli;
    • Sidiqi, M Hasib;
    • Jevremovic, Dragan;
    • Dispenzieri, Angela;
    • Gonsalves, Wilson;
    • Buadi, Francis;
    • Lacy, Martha;
    • Hayman, Suzanne;
    • Kourelis, Taxiarchis;
    • Kapoor, Prashant;
    • Go, Ronald;
    • Warsame, Rahma;
    • Leung, Nelson;
    • Rajkumar, S.Vincent;
    • Kyle, Robert;
    • Gertz, Morie A.;
    • Kumar, Shaji
    Publication type:
    Article
    46

    Blood mass spectrometry Detects Residual Disease Better than Standard Techniques in Immunoglobulin light chain amyloidosis.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e313, doi. 10.1016/j.clml.2019.09.514
    By:
    • Dispenzieri, Angela;
    • Arendt, Bonnie;
    • Dasari, Surendra;
    • Kohlhagen, Mindy;
    • Kourelis, Taxiarchis;
    • Kumar, Shaji;
    • Leung, Nelson;
    • Muchtar, Eli;
    • Buadi, Francis;
    • Warsame, Rahma;
    • Kyle, Robert;
    • Lacy, Martha;
    • Dingli, David;
    • Gonsalves, Wilson;
    • Kapoor, Prashant;
    • Go, Ronald;
    • Hwa, Yi Lisa;
    • Fonder, Amie;
    • Hobbs, Miriam;
    • Jevremovic, Dragan
    Publication type:
    Article
    47

    Venetoclax for the Treatment of Multiple Myeloma: Outcomes Outside of Clinical Trials.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e278, doi. 10.1016/j.clml.2019.09.459
    By:
    • Sidiqi, M Hasib;
    • Al Saleh, Abdullah S.;
    • Lee, JaeWon;
    • Jevremovic, Dragan;
    • Fonseca, Rafael;
    • Gertz, Morie A.;
    • Dispenzieri, Angela;
    • Buadi, Francis;
    • Lacy, Martha;
    • Leung, Nelson;
    • Muchtar, Eli;
    • Kyle, Robert;
    • Go, Ronald;
    • Hobbs, Miriam;
    • Gonsalves, Wilson;
    • Kourelis, Taxiarchis;
    • Warsame, Rahma;
    • Dingli, David;
    • Lust, John;
    • Hayman, Suzanne
    Publication type:
    Article
    48

    Outcomes with different administration schedules of VRD as first-line therapy in multiple myeloma: a retrospective analysis.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e203, doi. 10.1016/j.clml.2019.09.338
    By:
    • Cook, Joselle;
    • Sidana, Surbhi;
    • Gonsalves, Wilson;
    • Gertz, Morie A.;
    • Buadi, Francis;
    • Lacy, Martha;
    • Kapoor, Prashant;
    • Dispenzieri, Angela;
    • Kourelis, Taxiarchis;
    • Warsame, Rahma;
    • Dingli, David;
    • Fonder, Amie;
    • Hayman, Suzanne;
    • Hobbs, Miriam;
    • Hwa, Yi Lisa;
    • Kyle, Robert;
    • Leung, Nelson;
    • Go, Ronald;
    • Rajkumar, S.Vincent;
    • Kumar, Shaji
    Publication type:
    Article
    49

    A Hematopoietic Score Predicts Survival in Newly Diagnosed Multiple Myeloma Patients.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e85, doi. 10.1016/j.clml.2019.09.137
    By:
    • Al Saleh, Abdullah S.;
    • Sidiqi, M Hasib;
    • Dispenzieri, Angela;
    • Muchtar, Eli;
    • Buadi, Francis;
    • Warsame, Rahma;
    • Lacy, Martha;
    • Dingli, David;
    • Leung, Nelson;
    • Gonsalves, Wilson;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis;
    • Gertz, Morie A.;
    • Go, Ronald;
    • Kyle, Robert;
    • Rajkumar, S.Vincent;
    • Kumar, Shaji
    Publication type:
    Article
    50